Results 281 to 290 of about 4,894,740 (406)

Total neoadjuvant therapy in rectal cancer: The FOREST protocol, a patient‐centered approach that clusters two cohorts with different outcomes

open access: yesInternational Journal of Cancer, EarlyView.
What's New? Treatment strategies for rectal cancer are increasingly focused on organ preservation and tailored therapy. Total neoadjuvant therapy (TNT), which integrates radiotherapy and systemic chemotherapy prior to surgery, is especially promising in this regard.
Hector Guadalajara   +14 more
wiley   +1 more source

An examination for colo-rectal cancer in hemodialysis patients

open access: bronze, 1988
Masumi Komatsu   +8 more
openalex   +2 more sources

Effect of Laparoscopic-Assisted Resection vs Open Resection of Stage II or III Rectal Cancer on Pathologic Outcomes: The ACOSOG Z6051 Randomized Clinical Trial.

open access: yesJournal of the American Medical Association (JAMA), 2015
J. Fleshman   +24 more
semanticscholar   +1 more source

A comparison by mismatch repair status of real‐world characteristics and outcomes in patients with stage II/III rectal cancer in the Netherlands

open access: yesInternational Journal of Cancer, EarlyView.
What's New? Mismatch repair deficiency (dMMR) in rectal cancer is rare, and knowledge about tumor biological behavior, response to treatment, and clinical outcomes in this subset of patients is limited. This nationwide cohort study including 182 patients with dMMR rectal cancer found that they were younger and had more poorly differentiated tumors ...
Renee A. Lunenberg   +14 more
wiley   +1 more source

Local and National Trends in Emergency Presentation of Colon and Rectal Cancer. [PDF]

open access: yesJ Surg Oncol
Habermann A   +7 more
europepmc   +1 more source

Use of magnetic resonance imaging in rectal cancer patients: Society of Abdominal Radiology (SAR) rectal cancer disease-focused panel (DFP) recommendations 2017

open access: yesAbdominal Radiology, 2018
M. Gollub   +18 more
semanticscholar   +1 more source

Prospective validation of the modified metastatic colorectal cancer score (mCCS) in >600 patients with RAS‐wild‐type metastatic colorectal cancer treated with first‐line panitumumab plus FOLFIRI/FOLFOX: Final results of the non‐interventional study VALIDATE

open access: yesInternational Journal of Cancer, EarlyView.
What's New? Prognostic assessment in metastatic colorectal cancer (mCRC), which is currently based on scores derived from clinical trials, requires refinement to enhance treatment outcomes and quality of care. In this study, the authors evaluated real‐world data from the German tumor registry to prospectively validate a modified mCRC prognostic score ...
Karin Potthoff   +19 more
wiley   +1 more source

Quality of life after laparoscopic surgery for very low rectal cancer: A sub-analysis of the ultimate trial. [PDF]

open access: yesColorectal Dis
Hamamoto H   +27 more
europepmc   +1 more source

Evaluation of echographic diagnosis of rectal cancer by intrarectal ultrasonic examination.

open access: bronze, 1984
N. Saitoh   +6 more
openalex   +2 more sources

Home - About - Disclaimer - Privacy